Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis
Abstract Background Preeclampsia (PE) is a new-onset pregnancy-specific disorder with a high prevalence that leads to over 70 000 maternal and 500 000 foetal fatalities worldwide each year. The level of chemerin, a newly identified adipokine, is increased in diabetic and obese patients. Currently, t...
Main Authors: | Yangxue Yin, Shuangshuang Xie, Qin Xu, Lingyun Liao, Hongqin Chen, Rong Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12944-023-01941-w |
Similar Items
-
Raised levels of chemerin in women with preeclampsia: A meta-analysis
by: Yue Xie, et al.
Published: (2023-09-01) -
Role of Chemerin in Cardiovascular Diseases
by: Mirjana T. Macvanin, et al.
Published: (2022-11-01) -
Adipokine chemerin overexpression in trophoblasts leads to dyslipidemia in pregnant mice: implications for preeclampsia
by: Lunbo Tan, et al.
Published: (2023-01-01) -
Third‐Trimester Maternal Serum Chemerin and Hypertension After Preeclampsia: A Prospective Cohort Study
by: Yixuan Chen, et al.
Published: (2023-03-01) -
Methodological utility of chemerin as a novel biomarker of immunity and metabolism
by: Fabian Eichelmann, et al.
Published: (2017-07-01)